Insulet Corp. (NASDAQ: PODD) Stock Competitors & Peer Comparison
See PODD's competitors and their performance on the NASDAQ and across the wider stock market.
Peer Comparison Table: Medical - Devices Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for PODD and its NASDAQ peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| PODD | $141.17 | +1.34% | 9.8B | 24.05 | $5.87 | N/A |
| ABT | $107.81 | -0.14% | 186.5B | 20.69 | $5.21 | +2.31% |
| BSX-PA | $122.18 | +2.37% | 175.4B | 230.53 | $0.53 | N/A |
| SYK | $339.03 | +0.47% | 130B | 25.32 | $13.39 | +1.03% |
| MDT | $87.16 | +1.44% | 111.6B | 15.76 | $5.53 | +3.29% |
| BSX | $49.31 | +0.02% | 73.3B | 15.91 | $3.10 | N/A |
| EW | $89.72 | +0.45% | 51.7B | 33.23 | $2.70 | N/A |
| DXCM | $84.75 | +2.08% | 32B | 36.37 | $2.33 | N/A |
| RMD | $211.94 | -5.06% | 30.7B | 19.68 | $10.77 | +1.15% |
| PHG | $26.73 | +1.52% | 26.1B | 15.28 | $1.75 | +3.70% |
Stock Comparison
Abbott Laboratories (NYSE: ABT)
PODD vs ABT Comparison August 2026
Insulet Corp. (NASDAQ: PODD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PODD stands at 9.8B. In comparison, ABT has a market cap of 186.5B. Regarding current trading prices, PODD is priced at $141.17 on the NASDAQ, while ABT trades at $107.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PODD currently has a P/E ratio of 24.05, whereas ABT's P/E ratio is 20.69. In terms of profitability, PODD's ROE is +0.27%, compared to ABT's ROE of +0.11%. Regarding short-term risk, PODD is more volatile compared to ABT. This indicates higher risk in terms of short-term price fluctuations for PODD.Check ABT's competition here
Boston Scientific Corporation (NYSE: BSX-PA)
PODD vs BSX-PA Comparison August 2026
Insulet Corp. (NASDAQ: PODD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PODD stands at 9.8B. In comparison, BSX-PA has a market cap of 175.4B. Regarding current trading prices, PODD is priced at $141.17 on the NASDAQ, while BSX-PA trades at $122.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PODD currently has a P/E ratio of 24.05, whereas BSX-PA's P/E ratio is 230.53. In terms of profitability, PODD's ROE is +0.27%, compared to BSX-PA's ROE of +0.15%. Regarding short-term risk, PODD is more volatile compared to BSX-PA. This indicates higher risk in terms of short-term price fluctuations for PODD.Check BSX-PA's competition here
Stryker Corporation (NYSE: SYK)
PODD vs SYK Comparison August 2026
Insulet Corp. (NASDAQ: PODD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PODD stands at 9.8B. In comparison, SYK has a market cap of 130B. Regarding current trading prices, PODD is priced at $141.17 on the NASDAQ, while SYK trades at $339.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PODD currently has a P/E ratio of 24.05, whereas SYK's P/E ratio is 25.32. In terms of profitability, PODD's ROE is +0.27%, compared to SYK's ROE of +0.16%. Regarding short-term risk, PODD is more volatile compared to SYK. This indicates higher risk in terms of short-term price fluctuations for PODD.Check SYK's competition here
Medtronic plc (NYSE: MDT)
PODD vs MDT Comparison August 2026
Insulet Corp. (NASDAQ: PODD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PODD stands at 9.8B. In comparison, MDT has a market cap of 111.6B. Regarding current trading prices, PODD is priced at $141.17 on the NASDAQ, while MDT trades at $87.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PODD currently has a P/E ratio of 24.05, whereas MDT's P/E ratio is 15.76. In terms of profitability, PODD's ROE is +0.27%, compared to MDT's ROE of +0.10%. Regarding short-term risk, PODD is more volatile compared to MDT. This indicates higher risk in terms of short-term price fluctuations for PODD.Check MDT's competition here
Boston Scientific Corporation (NYSE: BSX)
PODD vs BSX Comparison August 2026
Insulet Corp. (NASDAQ: PODD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PODD stands at 9.8B. In comparison, BSX has a market cap of 73.3B. Regarding current trading prices, PODD is priced at $141.17 on the NASDAQ, while BSX trades at $49.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PODD currently has a P/E ratio of 24.05, whereas BSX's P/E ratio is 15.91. In terms of profitability, PODD's ROE is +0.27%, compared to BSX's ROE of +0.15%. Regarding short-term risk, PODD is more volatile compared to BSX. This indicates higher risk in terms of short-term price fluctuations for PODD.Check BSX's competition here
Edwards Lifesciences Corporation (NYSE: EW)
PODD vs EW Comparison August 2026
Insulet Corp. (NASDAQ: PODD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PODD stands at 9.8B. In comparison, EW has a market cap of 51.7B. Regarding current trading prices, PODD is priced at $141.17 on the NASDAQ, while EW trades at $89.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PODD currently has a P/E ratio of 24.05, whereas EW's P/E ratio is 33.23. In terms of profitability, PODD's ROE is +0.27%, compared to EW's ROE of +0.10%. Regarding short-term risk, PODD is more volatile compared to EW. This indicates higher risk in terms of short-term price fluctuations for PODD.Check EW's competition here
DexCom, Inc. (NASDAQ: DXCM)
PODD vs DXCM Comparison August 2026
Insulet Corp. (NASDAQ: PODD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PODD stands at 9.8B. In comparison, DXCM has a market cap of 32B. Regarding current trading prices, PODD is priced at $141.17 on the NASDAQ, while DXCM trades at $84.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PODD currently has a P/E ratio of 24.05, whereas DXCM's P/E ratio is 36.37. In terms of profitability, PODD's ROE is +0.27%, compared to DXCM's ROE of +0.36%. Regarding short-term risk, PODD is more volatile compared to DXCM. This indicates higher risk in terms of short-term price fluctuations for PODD.Check DXCM's competition here
ResMed Inc. (NYSE: RMD)
PODD vs RMD Comparison August 2026
Insulet Corp. (NASDAQ: PODD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PODD stands at 9.8B. In comparison, RMD has a market cap of 30.7B. Regarding current trading prices, PODD is priced at $141.17 on the NASDAQ, while RMD trades at $211.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PODD currently has a P/E ratio of 24.05, whereas RMD's P/E ratio is 19.68. In terms of profitability, PODD's ROE is +0.27%, compared to RMD's ROE of +0.24%. Regarding short-term risk, PODD is less volatile compared to RMD. This indicates lower risk in terms of short-term price fluctuations for PODD.Check RMD's competition here
Koninklijke Philips N.V. (NYSE: PHG)
PODD vs PHG Comparison August 2026
Insulet Corp. (NASDAQ: PODD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PODD stands at 9.8B. In comparison, PHG has a market cap of 26.1B. Regarding current trading prices, PODD is priced at $141.17 on the NASDAQ, while PHG trades at $26.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PODD currently has a P/E ratio of 24.05, whereas PHG's P/E ratio is 15.28. In terms of profitability, PODD's ROE is +0.27%, compared to PHG's ROE of +0.10%. Regarding short-term risk, PODD is more volatile compared to PHG. This indicates higher risk in terms of short-term price fluctuations for PODD.Check PHG's competition here
Zimmer Biomet Holdings, Inc. (NYSE: ZBH)
PODD vs ZBH Comparison August 2026
Insulet Corp. (NASDAQ: PODD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PODD stands at 9.8B. In comparison, ZBH has a market cap of 18.7B. Regarding current trading prices, PODD is priced at $141.17 on the NASDAQ, while ZBH trades at $96.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PODD currently has a P/E ratio of 24.05, whereas ZBH's P/E ratio is 11.38. In terms of profitability, PODD's ROE is +0.27%, compared to ZBH's ROE of +0.06%. Regarding short-term risk, PODD is more volatile compared to ZBH. This indicates higher risk in terms of short-term price fluctuations for PODD.Check ZBH's competition here
Abiomed, Inc. (NASDAQ: ABMD)
PODD vs ABMD Comparison August 2026
Insulet Corp. (NASDAQ: PODD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PODD stands at 9.8B. In comparison, ABMD has a market cap of 17.2B. Regarding current trading prices, PODD is priced at $141.17 on the NASDAQ, while ABMD trades at $381.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PODD currently has a P/E ratio of 24.05, whereas ABMD's P/E ratio is 65.36. In terms of profitability, PODD's ROE is +0.27%, compared to ABMD's ROE of +0.10%. Regarding short-term risk, PODD is more volatile compared to ABMD. This indicates higher risk in terms of short-term price fluctuations for PODD.Check ABMD's competition here
Penumbra, Inc. (NYSE: PEN)
PODD vs PEN Comparison August 2026
Insulet Corp. (NASDAQ: PODD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PODD stands at 9.8B. In comparison, PEN has a market cap of 12.8B. Regarding current trading prices, PODD is priced at $141.17 on the NASDAQ, while PEN trades at $324.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PODD currently has a P/E ratio of 24.05, whereas PEN's P/E ratio is 84.77. In terms of profitability, PODD's ROE is +0.27%, compared to PEN's ROE of +0.11%. Regarding short-term risk, PODD is more volatile compared to PEN. This indicates higher risk in terms of short-term price fluctuations for PODD.Check PEN's competition here
Smith & Nephew plc (NYSE: SNN)
PODD vs SNN Comparison August 2026
Insulet Corp. (NASDAQ: PODD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PODD stands at 9.8B. In comparison, SNN has a market cap of 12.6B. Regarding current trading prices, PODD is priced at $141.17 on the NASDAQ, while SNN trades at $30.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PODD currently has a P/E ratio of 24.05, whereas SNN's P/E ratio is 14.16. In terms of profitability, PODD's ROE is +0.27%, compared to SNN's ROE of +0.12%. Regarding short-term risk, PODD is more volatile compared to SNN. This indicates higher risk in terms of short-term price fluctuations for PODD.Check SNN's competition here
ShockWave Medical, Inc. (NASDAQ: SWAV)
PODD vs SWAV Comparison August 2026
Insulet Corp. (NASDAQ: PODD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PODD stands at 9.8B. In comparison, SWAV has a market cap of 12.6B. Regarding current trading prices, PODD is priced at $141.17 on the NASDAQ, while SWAV trades at $334.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PODD currently has a P/E ratio of 24.05, whereas SWAV's P/E ratio is 78.76. In terms of profitability, PODD's ROE is +0.27%, compared to SWAV's ROE of +0.25%. Regarding short-term risk, PODD is more volatile compared to SWAV. This indicates higher risk in terms of short-term price fluctuations for PODD.Check SWAV's competition here
Align Technology, Inc. (NASDAQ: ALGN)
PODD vs ALGN Comparison August 2026
Insulet Corp. (NASDAQ: PODD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PODD stands at 9.8B. In comparison, ALGN has a market cap of 12.4B. Regarding current trading prices, PODD is priced at $141.17 on the NASDAQ, while ALGN trades at $173.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PODD currently has a P/E ratio of 24.05, whereas ALGN's P/E ratio is 15.83. In terms of profitability, PODD's ROE is +0.27%, compared to ALGN's ROE of +0.14%. Regarding short-term risk, PODD is less volatile compared to ALGN. This indicates lower risk in terms of short-term price fluctuations for PODD.Check ALGN's competition here
Globus Medical, Inc. (NYSE: GMED)
PODD vs GMED Comparison August 2026
Insulet Corp. (NASDAQ: PODD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PODD stands at 9.8B. In comparison, GMED has a market cap of 11.1B. Regarding current trading prices, PODD is priced at $141.17 on the NASDAQ, while GMED trades at $82.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PODD currently has a P/E ratio of 24.05, whereas GMED's P/E ratio is 18.56. In terms of profitability, PODD's ROE is +0.27%, compared to GMED's ROE of +0.12%. Regarding short-term risk, PODD is less volatile compared to GMED. This indicates lower risk in terms of short-term price fluctuations for PODD.Check GMED's competition here
Glaukos Corporation (NYSE: GKOS)
PODD vs GKOS Comparison August 2026
Insulet Corp. (NASDAQ: PODD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PODD stands at 9.8B. In comparison, GKOS has a market cap of 10.6B. Regarding current trading prices, PODD is priced at $141.17 on the NASDAQ, while GKOS trades at $180.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PODD currently has a P/E ratio of 24.05, whereas GKOS's P/E ratio is -209.45. In terms of profitability, PODD's ROE is +0.27%, compared to GKOS's ROE of -0.27%. Regarding short-term risk, PODD is less volatile compared to GKOS. This indicates lower risk in terms of short-term price fluctuations for PODD.Check GKOS's competition here
Bio-Rad Laboratories, Inc. (NYSE: BIO-B)
PODD vs BIO-B Comparison August 2026
Insulet Corp. (NASDAQ: PODD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PODD stands at 9.8B. In comparison, BIO-B has a market cap of 9.5B. Regarding current trading prices, PODD is priced at $141.17 on the NASDAQ, while BIO-B trades at $349.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PODD currently has a P/E ratio of 24.05, whereas BIO-B's P/E ratio is 103.54. In terms of profitability, PODD's ROE is +0.27%, compared to BIO-B's ROE of +0.03%. Regarding short-term risk, PODD is more volatile compared to BIO-B. This indicates higher risk in terms of short-term price fluctuations for PODD.Check BIO-B's competition here
Bio-Rad Laboratories, Inc. (NYSE: BIO)
PODD vs BIO Comparison August 2026
Insulet Corp. (NASDAQ: PODD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PODD stands at 9.8B. In comparison, BIO has a market cap of 9.5B. Regarding current trading prices, PODD is priced at $141.17 on the NASDAQ, while BIO trades at $352.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PODD currently has a P/E ratio of 24.05, whereas BIO's P/E ratio is 38.00. In terms of profitability, PODD's ROE is +0.27%, compared to BIO's ROE of +0.03%. Regarding short-term risk, PODD is more volatile compared to BIO. This indicates higher risk in terms of short-term price fluctuations for PODD.Check BIO's competition here
Masimo Corporation (NASDAQ: MASI)
PODD vs MASI Comparison August 2026
Insulet Corp. (NASDAQ: PODD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PODD stands at 9.8B. In comparison, MASI has a market cap of 9.4B. Regarding current trading prices, PODD is priced at $141.17 on the NASDAQ, while MASI trades at $179.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PODD currently has a P/E ratio of 24.05, whereas MASI's P/E ratio is 44.43. In terms of profitability, PODD's ROE is +0.27%, compared to MASI's ROE of +0.09%. Regarding short-term risk, PODD is more volatile compared to MASI. This indicates higher risk in terms of short-term price fluctuations for PODD.Check MASI's competition here
Bruker Corporation (NASDAQ: BRKR)
PODD vs BRKR Comparison August 2026
Insulet Corp. (NASDAQ: PODD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PODD stands at 9.8B. In comparison, BRKR has a market cap of 8.1B. Regarding current trading prices, PODD is priced at $141.17 on the NASDAQ, while BRKR trades at $53.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PODD currently has a P/E ratio of 24.05, whereas BRKR's P/E ratio is 26.84. In terms of profitability, PODD's ROE is +0.27%, compared to BRKR's ROE of -0.03%. Regarding short-term risk, PODD is less volatile compared to BRKR. This indicates lower risk in terms of short-term price fluctuations for PODD.Check BRKR's competition here
Inari Medical, Inc. (NASDAQ: NARI)
PODD vs NARI Comparison August 2026
Insulet Corp. (NASDAQ: PODD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PODD stands at 9.8B. In comparison, NARI has a market cap of 4.7B. Regarding current trading prices, PODD is priced at $141.17 on the NASDAQ, while NARI trades at $79.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PODD currently has a P/E ratio of 24.05, whereas NARI's P/E ratio is -59.24. In terms of profitability, PODD's ROE is +0.27%, compared to NARI's ROE of -0.00%. Regarding short-term risk, PODD is more volatile compared to NARI. This indicates higher risk in terms of short-term price fluctuations for PODD.Check NARI's competition here
Integer Holdings Corporation (NYSE: ITGR)
PODD vs ITGR Comparison August 2026
Insulet Corp. (NASDAQ: PODD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PODD stands at 9.8B. In comparison, ITGR has a market cap of 4.3B. Regarding current trading prices, PODD is priced at $141.17 on the NASDAQ, while ITGR trades at $125.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PODD currently has a P/E ratio of 24.05, whereas ITGR's P/E ratio is 19.72. In terms of profitability, PODD's ROE is +0.27%, compared to ITGR's ROE of +0.07%. Regarding short-term risk, PODD is more volatile compared to ITGR. This indicates higher risk in terms of short-term price fluctuations for PODD.Check ITGR's competition here
iRhythm Technologies, Inc. (NASDAQ: IRTC)
PODD vs IRTC Comparison August 2026
Insulet Corp. (NASDAQ: PODD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PODD stands at 9.8B. In comparison, IRTC has a market cap of 4.2B. Regarding current trading prices, PODD is priced at $141.17 on the NASDAQ, while IRTC trades at $127.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PODD currently has a P/E ratio of 24.05, whereas IRTC's P/E ratio is -199.75. In terms of profitability, PODD's ROE is +0.27%, compared to IRTC's ROE of -0.09%. Regarding short-term risk, PODD is less volatile compared to IRTC. This indicates lower risk in terms of short-term price fluctuations for PODD.Check IRTC's competition here
LivaNova PLC (NASDAQ: LIVN)
PODD vs LIVN Comparison August 2026
Insulet Corp. (NASDAQ: PODD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PODD stands at 9.8B. In comparison, LIVN has a market cap of 4.2B. Regarding current trading prices, PODD is priced at $141.17 on the NASDAQ, while LIVN trades at $76.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PODD currently has a P/E ratio of 24.05, whereas LIVN's P/E ratio is 18.10. In terms of profitability, PODD's ROE is +0.27%, compared to LIVN's ROE of +0.15%. Regarding short-term risk, PODD is more volatile compared to LIVN. This indicates higher risk in terms of short-term price fluctuations for PODD.Check LIVN's competition here
Haemonetics Corporation (NYSE: HAE)
PODD vs HAE Comparison August 2026
Insulet Corp. (NASDAQ: PODD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PODD stands at 9.8B. In comparison, HAE has a market cap of 4B. Regarding current trading prices, PODD is priced at $141.17 on the NASDAQ, while HAE trades at $87.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PODD currently has a P/E ratio of 24.05, whereas HAE's P/E ratio is 17.54. In terms of profitability, PODD's ROE is +0.27%, compared to HAE's ROE of +0.11%. Regarding short-term risk, PODD is more volatile compared to HAE. This indicates higher risk in terms of short-term price fluctuations for PODD.Check HAE's competition here
Axonics, Inc. (NASDAQ: AXNX)
PODD vs AXNX Comparison August 2026
Insulet Corp. (NASDAQ: PODD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PODD stands at 9.8B. In comparison, AXNX has a market cap of 3.6B. Regarding current trading prices, PODD is priced at $141.17 on the NASDAQ, while AXNX trades at $70.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PODD currently has a P/E ratio of 24.05, whereas AXNX's P/E ratio is -709.80. In terms of profitability, PODD's ROE is +0.27%, compared to AXNX's ROE of -0.01%. Regarding short-term risk, PODD is more volatile compared to AXNX. This indicates higher risk in terms of short-term price fluctuations for PODD.Check AXNX's competition here
TransMedics Group, Inc. (NASDAQ: TMDX)
PODD vs TMDX Comparison August 2026
Insulet Corp. (NASDAQ: PODD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PODD stands at 9.8B. In comparison, TMDX has a market cap of 2.9B. Regarding current trading prices, PODD is priced at $141.17 on the NASDAQ, while TMDX trades at $83.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PODD currently has a P/E ratio of 24.05, whereas TMDX's P/E ratio is 42.58. In terms of profitability, PODD's ROE is +0.27%, compared to TMDX's ROE of +0.33%. Regarding short-term risk, PODD is less volatile compared to TMDX. This indicates lower risk in terms of short-term price fluctuations for PODD.Check TMDX's competition here
AxoGen, Inc. (NASDAQ: AXGN)
PODD vs AXGN Comparison August 2026
Insulet Corp. (NASDAQ: PODD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PODD stands at 9.8B. In comparison, AXGN has a market cap of 2.5B. Regarding current trading prices, PODD is priced at $141.17 on the NASDAQ, while AXGN trades at $46.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PODD currently has a P/E ratio of 24.05, whereas AXGN's P/E ratio is 122.18. In terms of profitability, PODD's ROE is +0.27%, compared to AXGN's ROE of -0.18%. Regarding short-term risk, PODD is less volatile compared to AXGN. This indicates lower risk in terms of short-term price fluctuations for PODD.Check AXGN's competition here
UFP Technologies, Inc. (NASDAQ: UFPT)
PODD vs UFPT Comparison August 2026
Insulet Corp. (NASDAQ: PODD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PODD stands at 9.8B. In comparison, UFPT has a market cap of 2.4B. Regarding current trading prices, PODD is priced at $141.17 on the NASDAQ, while UFPT trades at $314.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PODD currently has a P/E ratio of 24.05, whereas UFPT's P/E ratio is 32.07. In terms of profitability, PODD's ROE is +0.27%, compared to UFPT's ROE of +0.17%. Regarding short-term risk, PODD is more volatile compared to UFPT. This indicates higher risk in terms of short-term price fluctuations for PODD.Check UFPT's competition here
Butterfly Network, Inc. (NYSE: BFLY)
PODD vs BFLY Comparison August 2026
Insulet Corp. (NASDAQ: PODD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PODD stands at 9.8B. In comparison, BFLY has a market cap of 2.3B. Regarding current trading prices, PODD is priced at $141.17 on the NASDAQ, while BFLY trades at $8.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PODD currently has a P/E ratio of 24.05, whereas BFLY's P/E ratio is -36.77. In terms of profitability, PODD's ROE is +0.27%, compared to BFLY's ROE of -0.38%. Regarding short-term risk, PODD is less volatile compared to BFLY. This indicates lower risk in terms of short-term price fluctuations for PODD.Check BFLY's competition here
Establishment Labs Holdings Inc. (NASDAQ: ESTA)
PODD vs ESTA Comparison August 2026
Insulet Corp. (NASDAQ: PODD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PODD stands at 9.8B. In comparison, ESTA has a market cap of 2.3B. Regarding current trading prices, PODD is priced at $141.17 on the NASDAQ, while ESTA trades at $77.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PODD currently has a P/E ratio of 24.05, whereas ESTA's P/E ratio is -61.44. In terms of profitability, PODD's ROE is +0.27%, compared to ESTA's ROE of -2.04%. Regarding short-term risk, PODD is less volatile compared to ESTA. This indicates lower risk in terms of short-term price fluctuations for PODD.Check ESTA's competition here
NuVasive, Inc. (NASDAQ: NUVA)
PODD vs NUVA Comparison August 2026
Insulet Corp. (NASDAQ: PODD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PODD stands at 9.8B. In comparison, NUVA has a market cap of 2.1B. Regarding current trading prices, PODD is priced at $141.17 on the NASDAQ, while NUVA trades at $39.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PODD currently has a P/E ratio of 24.05, whereas NUVA's P/E ratio is 75.00. In terms of profitability, PODD's ROE is +0.27%, compared to NUVA's ROE of +0.05%. Regarding short-term risk, PODD is more volatile compared to NUVA. This indicates higher risk in terms of short-term price fluctuations for PODD.Check NUVA's competition here
Novocure Ltd (NASDAQ: NVCR)
PODD vs NVCR Comparison August 2026
Insulet Corp. (NASDAQ: PODD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PODD stands at 9.8B. In comparison, NVCR has a market cap of 1.9B. Regarding current trading prices, PODD is priced at $141.17 on the NASDAQ, while NVCR trades at $16.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PODD currently has a P/E ratio of 24.05, whereas NVCR's P/E ratio is -10.71. In terms of profitability, PODD's ROE is +0.27%, compared to NVCR's ROE of -0.44%. Regarding short-term risk, PODD is less volatile compared to NVCR. This indicates lower risk in terms of short-term price fluctuations for PODD.Check NVCR's competition here
Inspire Medical Systems, Inc. (NYSE: INSP)
PODD vs INSP Comparison August 2026
Insulet Corp. (NASDAQ: PODD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PODD stands at 9.8B. In comparison, INSP has a market cap of 1.7B. Regarding current trading prices, PODD is priced at $141.17 on the NASDAQ, while INSP trades at $60.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PODD currently has a P/E ratio of 24.05, whereas INSP's P/E ratio is 26.51. In terms of profitability, PODD's ROE is +0.27%, compared to INSP's ROE of +0.18%. Regarding short-term risk, PODD is more volatile compared to INSP. This indicates higher risk in terms of short-term price fluctuations for PODD.Check INSP's competition here
Tandem Diabetes Care, Inc. (NASDAQ: TNDM)
PODD vs TNDM Comparison August 2026
Insulet Corp. (NASDAQ: PODD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PODD stands at 9.8B. In comparison, TNDM has a market cap of 1.5B. Regarding current trading prices, PODD is priced at $141.17 on the NASDAQ, while TNDM trades at $22.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PODD currently has a P/E ratio of 24.05, whereas TNDM's P/E ratio is -20.35. In terms of profitability, PODD's ROE is +0.27%, compared to TNDM's ROE of -0.46%. Regarding short-term risk, PODD is less volatile compared to TNDM. This indicates lower risk in terms of short-term price fluctuations for PODD.Check TNDM's competition here
Enovis Corporation (NYSE: ENOV)
PODD vs ENOV Comparison August 2026
Insulet Corp. (NASDAQ: PODD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PODD stands at 9.8B. In comparison, ENOV has a market cap of 1.5B. Regarding current trading prices, PODD is priced at $141.17 on the NASDAQ, while ENOV trades at $26.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PODD currently has a P/E ratio of 24.05, whereas ENOV's P/E ratio is 7.62. In terms of profitability, PODD's ROE is +0.27%, compared to ENOV's ROE of -0.68%. Regarding short-term risk, PODD is less volatile compared to ENOV. This indicates lower risk in terms of short-term price fluctuations for PODD.Check ENOV's competition here
CONMED Corporation (NYSE: CNMD)
PODD vs CNMD Comparison August 2026
Insulet Corp. (NASDAQ: PODD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PODD stands at 9.8B. In comparison, CNMD has a market cap of 1.5B. Regarding current trading prices, PODD is priced at $141.17 on the NASDAQ, while CNMD trades at $49.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PODD currently has a P/E ratio of 24.05, whereas CNMD's P/E ratio is 10.78. In terms of profitability, PODD's ROE is +0.27%, compared to CNMD's ROE of +0.06%. Regarding short-term risk, PODD is more volatile compared to CNMD. This indicates higher risk in terms of short-term price fluctuations for PODD.Check CNMD's competition here
Alphatec Holdings, Inc. (NASDAQ: ATEC)
PODD vs ATEC Comparison August 2026
Insulet Corp. (NASDAQ: PODD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PODD stands at 9.8B. In comparison, ATEC has a market cap of 1.4B. Regarding current trading prices, PODD is priced at $141.17 on the NASDAQ, while ATEC trades at $9.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PODD currently has a P/E ratio of 24.05, whereas ATEC's P/E ratio is -155.17. In terms of profitability, PODD's ROE is +0.27%, compared to ATEC's ROE of -8.19%. Regarding short-term risk, PODD is more volatile compared to ATEC. This indicates higher risk in terms of short-term price fluctuations for PODD.Check ATEC's competition here
Integra LifeSciences Holdings Corporation (NASDAQ: IART)
PODD vs IART Comparison August 2026
Insulet Corp. (NASDAQ: PODD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PODD stands at 9.8B. In comparison, IART has a market cap of 1.3B. Regarding current trading prices, PODD is priced at $141.17 on the NASDAQ, while IART trades at $17.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PODD currently has a P/E ratio of 24.05, whereas IART's P/E ratio is 7.31. In terms of profitability, PODD's ROE is +0.27%, compared to IART's ROE of -0.01%. Regarding short-term risk, PODD is more volatile compared to IART. This indicates higher risk in terms of short-term price fluctuations for PODD.Check IART's competition here
Artivion, Inc. (NYSE: AORT)
PODD vs AORT Comparison August 2026
Insulet Corp. (NASDAQ: PODD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PODD stands at 9.8B. In comparison, AORT has a market cap of 1.3B. Regarding current trading prices, PODD is priced at $141.17 on the NASDAQ, while AORT trades at $27.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PODD currently has a P/E ratio of 24.05, whereas AORT's P/E ratio is 45.28. In terms of profitability, PODD's ROE is +0.27%, compared to AORT's ROE of -0.01%. Regarding short-term risk, PODD is less volatile compared to AORT. This indicates lower risk in terms of short-term price fluctuations for PODD.Check AORT's competition here
Heska Corporation (NASDAQ: HSKA)
PODD vs HSKA Comparison August 2026
Insulet Corp. (NASDAQ: PODD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PODD stands at 9.8B. In comparison, HSKA has a market cap of 1.3B. Regarding current trading prices, PODD is priced at $141.17 on the NASDAQ, while HSKA trades at $119.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PODD currently has a P/E ratio of 24.05, whereas HSKA's P/E ratio is -62.49. In terms of profitability, PODD's ROE is +0.27%, compared to HSKA's ROE of -0.04%. Regarding short-term risk, PODD is more volatile compared to HSKA. This indicates higher risk in terms of short-term price fluctuations for PODD.Check HSKA's competition here
IRadimed Corporation (NASDAQ: IRMD)
PODD vs IRMD Comparison August 2026
Insulet Corp. (NASDAQ: PODD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PODD stands at 9.8B. In comparison, IRMD has a market cap of 1.2B. Regarding current trading prices, PODD is priced at $141.17 on the NASDAQ, while IRMD trades at $92.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PODD currently has a P/E ratio of 24.05, whereas IRMD's P/E ratio is 46.48. In terms of profitability, PODD's ROE is +0.27%, compared to IRMD's ROE of +0.23%. Regarding short-term risk, PODD is more volatile compared to IRMD. This indicates higher risk in terms of short-term price fluctuations for PODD.Check IRMD's competition here
Avanos Medical, Inc. (NYSE: AVNS)
PODD vs AVNS Comparison August 2026
Insulet Corp. (NASDAQ: PODD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PODD stands at 9.8B. In comparison, AVNS has a market cap of 1.2B. Regarding current trading prices, PODD is priced at $141.17 on the NASDAQ, while AVNS trades at $24.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PODD currently has a P/E ratio of 24.05, whereas AVNS's P/E ratio is 27.77. In terms of profitability, PODD's ROE is +0.27%, compared to AVNS's ROE of -0.09%. Regarding short-term risk, PODD is more volatile compared to AVNS. This indicates higher risk in terms of short-term price fluctuations for PODD.Check AVNS's competition here
PROCEPT BioRobotics Corporation (NASDAQ: PRCT)
PODD vs PRCT Comparison August 2026
Insulet Corp. (NASDAQ: PODD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PODD stands at 9.8B. In comparison, PRCT has a market cap of 1.2B. Regarding current trading prices, PODD is priced at $141.17 on the NASDAQ, while PRCT trades at $20.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PODD currently has a P/E ratio of 24.05, whereas PRCT's P/E ratio is -10.52. In terms of profitability, PODD's ROE is +0.27%, compared to PRCT's ROE of -0.31%. Regarding short-term risk, PODD is less volatile compared to PRCT. This indicates lower risk in terms of short-term price fluctuations for PODD.Check PRCT's competition here
Silk Road Medical, Inc (NASDAQ: SILK)
PODD vs SILK Comparison August 2026
Insulet Corp. (NASDAQ: PODD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PODD stands at 9.8B. In comparison, SILK has a market cap of 1.1B. Regarding current trading prices, PODD is priced at $141.17 on the NASDAQ, while SILK trades at $27.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PODD currently has a P/E ratio of 24.05, whereas SILK's P/E ratio is -18.96. In terms of profitability, PODD's ROE is +0.27%, compared to SILK's ROE of -0.35%. Regarding short-term risk, PODD is more volatile compared to SILK. This indicates higher risk in terms of short-term price fluctuations for PODD.Check SILK's competition here
Lumexa Imaging Holdings, Inc. Common Stock (NASDAQ: LMRI)
PODD vs LMRI Comparison August 2026
Insulet Corp. (NASDAQ: PODD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PODD stands at 9.8B. In comparison, LMRI has a market cap of 1.1B. Regarding current trading prices, PODD is priced at $141.17 on the NASDAQ, while LMRI trades at $11.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PODD currently has a P/E ratio of 24.05, whereas LMRI's P/E ratio is -22.53. In terms of profitability, PODD's ROE is +0.27%, compared to LMRI's ROE of -0.06%. Regarding short-term risk, PODD is less volatile compared to LMRI. This indicates lower risk in terms of short-term price fluctuations for PODD.Check LMRI's competition here
Paragon 28, Inc. (NYSE: FNA)
PODD vs FNA Comparison August 2026
Insulet Corp. (NASDAQ: PODD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PODD stands at 9.8B. In comparison, FNA has a market cap of 1.1B. Regarding current trading prices, PODD is priced at $141.17 on the NASDAQ, while FNA trades at $13.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PODD currently has a P/E ratio of 24.05, whereas FNA's P/E ratio is -19.83. In terms of profitability, PODD's ROE is +0.27%, compared to FNA's ROE of -0.35%. Regarding short-term risk, PODD is more volatile compared to FNA. This indicates higher risk in terms of short-term price fluctuations for PODD.Check FNA's competition here
Bioventus Inc. (NASDAQ: BVS)
PODD vs BVS Comparison August 2026
Insulet Corp. (NASDAQ: PODD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PODD stands at 9.8B. In comparison, BVS has a market cap of 956.9M. Regarding current trading prices, PODD is priced at $141.17 on the NASDAQ, while BVS trades at $14.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PODD currently has a P/E ratio of 24.05, whereas BVS's P/E ratio is 18.59. In terms of profitability, PODD's ROE is +0.27%, compared to BVS's ROE of +0.28%. Regarding short-term risk, PODD is more volatile compared to BVS. This indicates higher risk in terms of short-term price fluctuations for PODD.Check BVS's competition here
InMode Ltd. (NASDAQ: INMD)
PODD vs INMD Comparison August 2026
Insulet Corp. (NASDAQ: PODD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PODD stands at 9.8B. In comparison, INMD has a market cap of 880M. Regarding current trading prices, PODD is priced at $141.17 on the NASDAQ, while INMD trades at $15.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PODD currently has a P/E ratio of 24.05, whereas INMD's P/E ratio is 10.63. In terms of profitability, PODD's ROE is +0.27%, compared to INMD's ROE of +0.13%. Regarding short-term risk, PODD is more volatile compared to INMD. This indicates higher risk in terms of short-term price fluctuations for PODD.Check INMD's competition here
Anteris Technologies Global Corp. (NASDAQ: AVR)
PODD vs AVR Comparison August 2026
Insulet Corp. (NASDAQ: PODD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PODD stands at 9.8B. In comparison, AVR has a market cap of 866.3M. Regarding current trading prices, PODD is priced at $141.17 on the NASDAQ, while AVR trades at $8.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PODD currently has a P/E ratio of 24.05, whereas AVR's P/E ratio is -4.00. In terms of profitability, PODD's ROE is +0.27%, compared to AVR's ROE of -1.24%. Regarding short-term risk, PODD is less volatile compared to AVR. This indicates lower risk in terms of short-term price fluctuations for PODD.Check AVR's competition here
Cardiovascular Systems, Inc. (NASDAQ: CSII)
PODD vs CSII Comparison August 2026
Insulet Corp. (NASDAQ: PODD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PODD stands at 9.8B. In comparison, CSII has a market cap of 844M. Regarding current trading prices, PODD is priced at $141.17 on the NASDAQ, while CSII trades at $20.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PODD currently has a P/E ratio of 24.05, whereas CSII's P/E ratio is -20.83. In terms of profitability, PODD's ROE is +0.27%, compared to CSII's ROE of -0.14%. Regarding short-term risk, PODD is more volatile compared to CSII. This indicates higher risk in terms of short-term price fluctuations for PODD.Check CSII's competition here
SI-BONE, Inc. (NASDAQ: SIBN)
PODD vs SIBN Comparison August 2026
Insulet Corp. (NASDAQ: PODD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PODD stands at 9.8B. In comparison, SIBN has a market cap of 825.3M. Regarding current trading prices, PODD is priced at $141.17 on the NASDAQ, while SIBN trades at $18.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PODD currently has a P/E ratio of 24.05, whereas SIBN's P/E ratio is -54.74. In terms of profitability, PODD's ROE is +0.27%, compared to SIBN's ROE of -0.08%. Regarding short-term risk, PODD is more volatile compared to SIBN. This indicates higher risk in terms of short-term price fluctuations for PODD.Check SIBN's competition here
AdaptHealth Corp. (NASDAQ: AHCO)
PODD vs AHCO Comparison August 2026
Insulet Corp. (NASDAQ: PODD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PODD stands at 9.8B. In comparison, AHCO has a market cap of 774.1M. Regarding current trading prices, PODD is priced at $141.17 on the NASDAQ, while AHCO trades at $5.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PODD currently has a P/E ratio of 24.05, whereas AHCO's P/E ratio is 11.61. In terms of profitability, PODD's ROE is +0.27%, compared to AHCO's ROE of -0.15%. Regarding short-term risk, PODD is less volatile compared to AHCO. This indicates lower risk in terms of short-term price fluctuations for PODD.Check AHCO's competition here
SS Innovations International, Inc. (NASDAQ: SSII)
PODD vs SSII Comparison August 2026
Insulet Corp. (NASDAQ: PODD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PODD stands at 9.8B. In comparison, SSII has a market cap of 754.5M. Regarding current trading prices, PODD is priced at $141.17 on the NASDAQ, while SSII trades at $3.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PODD currently has a P/E ratio of 24.05, whereas SSII's P/E ratio is -73.53. In terms of profitability, PODD's ROE is +0.27%, compared to SSII's ROE of -0.23%. Regarding short-term risk, PODD is less volatile compared to SSII. This indicates lower risk in terms of short-term price fluctuations for PODD.Check SSII's competition here
Beta Bionics, Inc. (NASDAQ: BBNX)
PODD vs BBNX Comparison August 2026
Insulet Corp. (NASDAQ: PODD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PODD stands at 9.8B. In comparison, BBNX has a market cap of 715.3M. Regarding current trading prices, PODD is priced at $141.17 on the NASDAQ, while BBNX trades at $15.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PODD currently has a P/E ratio of 24.05, whereas BBNX's P/E ratio is -10.53. In terms of profitability, PODD's ROE is +0.27%, compared to BBNX's ROE of -0.26%. Regarding short-term risk, PODD is less volatile compared to BBNX. This indicates lower risk in terms of short-term price fluctuations for PODD.Check BBNX's competition here
CeriBell, Inc. (NASDAQ: CBLL)
PODD vs CBLL Comparison August 2026
Insulet Corp. (NASDAQ: PODD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PODD stands at 9.8B. In comparison, CBLL has a market cap of 713.7M. Regarding current trading prices, PODD is priced at $141.17 on the NASDAQ, while CBLL trades at $18.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PODD currently has a P/E ratio of 24.05, whereas CBLL's P/E ratio is -11.54. In terms of profitability, PODD's ROE is +0.27%, compared to CBLL's ROE of -0.38%. Regarding short-term risk, PODD is more volatile compared to CBLL. This indicates higher risk in terms of short-term price fluctuations for PODD.Check CBLL's competition here
Tactile Systems Technology, Inc. (NASDAQ: TCMD)
PODD vs TCMD Comparison August 2026
Insulet Corp. (NASDAQ: PODD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PODD stands at 9.8B. In comparison, TCMD has a market cap of 665.4M. Regarding current trading prices, PODD is priced at $141.17 on the NASDAQ, while TCMD trades at $29.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PODD currently has a P/E ratio of 24.05, whereas TCMD's P/E ratio is 33.52. In terms of profitability, PODD's ROE is +0.27%, compared to TCMD's ROE of +0.10%. Regarding short-term risk, PODD is more volatile compared to TCMD. This indicates higher risk in terms of short-term price fluctuations for PODD.Check TCMD's competition here
Surmodics, Inc. (NASDAQ: SRDX)
PODD vs SRDX Comparison August 2026
Insulet Corp. (NASDAQ: PODD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PODD stands at 9.8B. In comparison, SRDX has a market cap of 614.5M. Regarding current trading prices, PODD is priced at $141.17 on the NASDAQ, while SRDX trades at $42.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PODD currently has a P/E ratio of 24.05, whereas SRDX's P/E ratio is -34.66. In terms of profitability, PODD's ROE is +0.27%, compared to SRDX's ROE of -0.10%. Regarding short-term risk, PODD is more volatile compared to SRDX. This indicates higher risk in terms of short-term price fluctuations for PODD.Check SRDX's competition here
BrainsWay Ltd. (NASDAQ: BWAY)
PODD vs BWAY Comparison August 2026
Insulet Corp. (NASDAQ: PODD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PODD stands at 9.8B. In comparison, BWAY has a market cap of 608M. Regarding current trading prices, PODD is priced at $141.17 on the NASDAQ, while BWAY trades at $15.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PODD currently has a P/E ratio of 24.05, whereas BWAY's P/E ratio is 39.38. In terms of profitability, PODD's ROE is +0.27%, compared to BWAY's ROE of +0.12%. Regarding short-term risk, PODD is less volatile compared to BWAY. This indicates lower risk in terms of short-term price fluctuations for PODD.Check BWAY's competition here
OrthoPediatrics Corp. (NASDAQ: KIDS)
PODD vs KIDS Comparison August 2026
Insulet Corp. (NASDAQ: PODD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PODD stands at 9.8B. In comparison, KIDS has a market cap of 584.8M. Regarding current trading prices, PODD is priced at $141.17 on the NASDAQ, while KIDS trades at $22.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PODD currently has a P/E ratio of 24.05, whereas KIDS's P/E ratio is -19.30. In terms of profitability, PODD's ROE is +0.27%, compared to KIDS's ROE of -0.12%. Regarding short-term risk, PODD is more volatile compared to KIDS. This indicates higher risk in terms of short-term price fluctuations for PODD.Check KIDS's competition here
Apollo Endosurgery, Inc. (NASDAQ: APEN)
PODD vs APEN Comparison August 2026
Insulet Corp. (NASDAQ: PODD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PODD stands at 9.8B. In comparison, APEN has a market cap of 579.7M. Regarding current trading prices, PODD is priced at $141.17 on the NASDAQ, while APEN trades at $10.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PODD currently has a P/E ratio of 24.05, whereas APEN's P/E ratio is -9.43. In terms of profitability, PODD's ROE is +0.27%, compared to APEN's ROE of -0.85%. Regarding short-term risk, PODD is more volatile compared to APEN. This indicates higher risk in terms of short-term price fluctuations for PODD.Check APEN's competition here
Cytek Biosciences, Inc. (NASDAQ: CTKB)
PODD vs CTKB Comparison August 2026
Insulet Corp. (NASDAQ: PODD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PODD stands at 9.8B. In comparison, CTKB has a market cap of 542.4M. Regarding current trading prices, PODD is priced at $141.17 on the NASDAQ, while CTKB trades at $4.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PODD currently has a P/E ratio of 24.05, whereas CTKB's P/E ratio is -22.25. In terms of profitability, PODD's ROE is +0.27%, compared to CTKB's ROE of -0.24%. Regarding short-term risk, PODD is more volatile compared to CTKB. This indicates higher risk in terms of short-term price fluctuations for PODD.Check CTKB's competition here
ZimVie Inc. (NASDAQ: ZIMV)
PODD vs ZIMV Comparison August 2026
Insulet Corp. (NASDAQ: PODD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PODD stands at 9.8B. In comparison, ZIMV has a market cap of 535.6M. Regarding current trading prices, PODD is priced at $141.17 on the NASDAQ, while ZIMV trades at $18.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PODD currently has a P/E ratio of 24.05, whereas ZIMV's P/E ratio is -27.52. In terms of profitability, PODD's ROE is +0.27%, compared to ZIMV's ROE of -0.01%. Regarding short-term risk, PODD is more volatile compared to ZIMV. This indicates higher risk in terms of short-term price fluctuations for PODD.Check ZIMV's competition here
Varex Imaging Corporation (NASDAQ: VREX)
PODD vs VREX Comparison August 2026
Insulet Corp. (NASDAQ: PODD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PODD stands at 9.8B. In comparison, VREX has a market cap of 522.5M. Regarding current trading prices, PODD is priced at $141.17 on the NASDAQ, while VREX trades at $12.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PODD currently has a P/E ratio of 24.05, whereas VREX's P/E ratio is 13.06. In terms of profitability, PODD's ROE is +0.27%, compared to VREX's ROE of -0.18%. Regarding short-term risk, PODD is more volatile compared to VREX. This indicates higher risk in terms of short-term price fluctuations for PODD.Check VREX's competition here
Delcath Systems, Inc. (NASDAQ: DCTH)
PODD vs DCTH Comparison August 2026
Insulet Corp. (NASDAQ: PODD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PODD stands at 9.8B. In comparison, DCTH has a market cap of 521.6M. Regarding current trading prices, PODD is priced at $141.17 on the NASDAQ, while DCTH trades at $15.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PODD currently has a P/E ratio of 24.05, whereas DCTH's P/E ratio is 1511.00. In terms of profitability, PODD's ROE is +0.27%, compared to DCTH's ROE of +0.00%. Regarding short-term risk, PODD is less volatile compared to DCTH. This indicates lower risk in terms of short-term price fluctuations for PODD.Check DCTH's competition here
NeuroPace, Inc. (NASDAQ: NPCE)
PODD vs NPCE Comparison August 2026
Insulet Corp. (NASDAQ: PODD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PODD stands at 9.8B. In comparison, NPCE has a market cap of 505.6M. Regarding current trading prices, PODD is priced at $141.17 on the NASDAQ, while NPCE trades at $14.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PODD currently has a P/E ratio of 24.05, whereas NPCE's P/E ratio is -25.57. In terms of profitability, PODD's ROE is +0.27%, compared to NPCE's ROE of -1.21%. Regarding short-term risk, PODD is less volatile compared to NPCE. This indicates lower risk in terms of short-term price fluctuations for PODD.Check NPCE's competition here
Cerus Corporation (NASDAQ: CERS)
PODD vs CERS Comparison August 2026
Insulet Corp. (NASDAQ: PODD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PODD stands at 9.8B. In comparison, CERS has a market cap of 473.6M. Regarding current trading prices, PODD is priced at $141.17 on the NASDAQ, while CERS trades at $2.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PODD currently has a P/E ratio of 24.05, whereas CERS's P/E ratio is -46.91. In terms of profitability, PODD's ROE is +0.27%, compared to CERS's ROE of -0.10%. Regarding short-term risk, PODD is less volatile compared to CERS. This indicates lower risk in terms of short-term price fluctuations for PODD.Check CERS's competition here
ClearPoint Neuro, Inc. (NASDAQ: CLPT)
PODD vs CLPT Comparison August 2026
Insulet Corp. (NASDAQ: PODD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PODD stands at 9.8B. In comparison, CLPT has a market cap of 426.2M. Regarding current trading prices, PODD is priced at $141.17 on the NASDAQ, while CLPT trades at $14.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PODD currently has a P/E ratio of 24.05, whereas CLPT's P/E ratio is -12.04. In terms of profitability, PODD's ROE is +0.27%, compared to CLPT's ROE of -1.88%. Regarding short-term risk, PODD is more volatile compared to CLPT. This indicates higher risk in terms of short-term price fluctuations for PODD.Check CLPT's competition here
Orthofix Medical Inc. (NASDAQ: OFIX)
PODD vs OFIX Comparison August 2026
Insulet Corp. (NASDAQ: PODD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PODD stands at 9.8B. In comparison, OFIX has a market cap of 415.5M. Regarding current trading prices, PODD is priced at $141.17 on the NASDAQ, while OFIX trades at $10.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PODD currently has a P/E ratio of 24.05, whereas OFIX's P/E ratio is -13.43. In terms of profitability, PODD's ROE is +0.27%, compared to OFIX's ROE of -0.14%. Regarding short-term risk, PODD is more volatile compared to OFIX. This indicates higher risk in terms of short-term price fluctuations for PODD.Check OFIX's competition here
Sight Sciences, Inc. (NASDAQ: SGHT)
PODD vs SGHT Comparison August 2026
Insulet Corp. (NASDAQ: PODD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PODD stands at 9.8B. In comparison, SGHT has a market cap of 406.4M. Regarding current trading prices, PODD is priced at $141.17 on the NASDAQ, while SGHT trades at $7.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PODD currently has a P/E ratio of 24.05, whereas SGHT's P/E ratio is -13.34. In terms of profitability, PODD's ROE is +0.27%, compared to SGHT's ROE of -0.51%. Regarding short-term risk, PODD is less volatile compared to SGHT. This indicates lower risk in terms of short-term price fluctuations for PODD.Check SGHT's competition here
Carlsmed, Inc. (NASDAQ: CARL)
PODD vs CARL Comparison August 2026
Insulet Corp. (NASDAQ: PODD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PODD stands at 9.8B. In comparison, CARL has a market cap of 375.7M. Regarding current trading prices, PODD is priced at $141.17 on the NASDAQ, while CARL trades at $13.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PODD currently has a P/E ratio of 24.05, whereas CARL's P/E ratio is -9.66. In terms of profitability, PODD's ROE is +0.27%, compared to CARL's ROE of -0.38%. Regarding short-term risk, PODD is more volatile compared to CARL. This indicates higher risk in terms of short-term price fluctuations for PODD.Check CARL's competition here
Pacific Biosciences of California, Inc. (NASDAQ: PACB)
PODD vs PACB Comparison August 2026
Insulet Corp. (NASDAQ: PODD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PODD stands at 9.8B. In comparison, PACB has a market cap of 368.1M. Regarding current trading prices, PODD is priced at $141.17 on the NASDAQ, while PACB trades at $1.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PODD currently has a P/E ratio of 24.05, whereas PACB's P/E ratio is -2.89. In terms of profitability, PODD's ROE is +0.27%, compared to PACB's ROE of -49.62%. Regarding short-term risk, PODD is less volatile compared to PACB. This indicates lower risk in terms of short-term price fluctuations for PODD.Check PACB's competition here
CapsoVision, Inc. (NASDAQ: CV)
PODD vs CV Comparison August 2026
Insulet Corp. (NASDAQ: PODD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PODD stands at 9.8B. In comparison, CV has a market cap of 354.7M. Regarding current trading prices, PODD is priced at $141.17 on the NASDAQ, while CV trades at $7.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PODD currently has a P/E ratio of 24.05, whereas CV's P/E ratio is -2.84. In terms of profitability, PODD's ROE is +0.27%, compared to CV's ROE of +1.27%. Regarding short-term risk, PODD is more volatile compared to CV. This indicates higher risk in terms of short-term price fluctuations for PODD.Check CV's competition here
Picard Medical, Inc. (AMEX: PMI)
PODD vs PMI Comparison August 2026
Insulet Corp. (NASDAQ: PODD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PODD stands at 9.8B. In comparison, PMI has a market cap of 349.2M. Regarding current trading prices, PODD is priced at $141.17 on the NASDAQ, while PMI trades at $3.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PODD currently has a P/E ratio of 24.05, whereas PMI's P/E ratio is -2.83. In terms of profitability, PODD's ROE is +0.27%, compared to PMI's ROE of +4.99%. Regarding short-term risk, PODD is less volatile compared to PMI. This indicates lower risk in terms of short-term price fluctuations for PODD.Check PMI's competition here
Electromed, Inc. (AMEX: ELMD)
PODD vs ELMD Comparison August 2026
Insulet Corp. (NASDAQ: PODD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PODD stands at 9.8B. In comparison, ELMD has a market cap of 348.5M. Regarding current trading prices, PODD is priced at $141.17 on the NASDAQ, while ELMD trades at $42.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PODD currently has a P/E ratio of 24.05, whereas ELMD's P/E ratio is 35.97. In terms of profitability, PODD's ROE is +0.27%, compared to ELMD's ROE of +0.22%. Regarding short-term risk, PODD is more volatile compared to ELMD. This indicates higher risk in terms of short-term price fluctuations for PODD.Check ELMD's competition here
Perspective Therapeutics, Inc. (AMEX: CATX)
PODD vs CATX Comparison August 2026
Insulet Corp. (NASDAQ: PODD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PODD stands at 9.8B. In comparison, CATX has a market cap of 342.1M. Regarding current trading prices, PODD is priced at $141.17 on the NASDAQ, while CATX trades at $3.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PODD currently has a P/E ratio of 24.05, whereas CATX's P/E ratio is -2.13. In terms of profitability, PODD's ROE is +0.27%, compared to CATX's ROE of -0.42%. Regarding short-term risk, PODD is more volatile compared to CATX. This indicates higher risk in terms of short-term price fluctuations for PODD.Check CATX's competition here
Semler Scientific, Inc. (NASDAQ: SMLR)
PODD vs SMLR Comparison August 2026
Insulet Corp. (NASDAQ: PODD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PODD stands at 9.8B. In comparison, SMLR has a market cap of 310.7M. Regarding current trading prices, PODD is priced at $141.17 on the NASDAQ, while SMLR trades at $20.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PODD currently has a P/E ratio of 24.05, whereas SMLR's P/E ratio is 3.92. In terms of profitability, PODD's ROE is +0.27%, compared to SMLR's ROE of +0.06%. Regarding short-term risk, PODD is more volatile compared to SMLR. This indicates higher risk in terms of short-term price fluctuations for PODD.Check SMLR's competition here
Treace Medical Concepts, Inc. (NASDAQ: TMCI)
PODD vs TMCI Comparison August 2026
Insulet Corp. (NASDAQ: PODD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PODD stands at 9.8B. In comparison, TMCI has a market cap of 308.8M. Regarding current trading prices, PODD is priced at $141.17 on the NASDAQ, while TMCI trades at $4.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PODD currently has a P/E ratio of 24.05, whereas TMCI's P/E ratio is -5.06. In terms of profitability, PODD's ROE is +0.27%, compared to TMCI's ROE of -0.74%. Regarding short-term risk, PODD is less volatile compared to TMCI. This indicates lower risk in terms of short-term price fluctuations for PODD.Check TMCI's competition here
Senseonics Holdings, Inc. (NASDAQ: SENS)
PODD vs SENS Comparison August 2026
Insulet Corp. (NASDAQ: PODD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PODD stands at 9.8B. In comparison, SENS has a market cap of 293.4M. Regarding current trading prices, PODD is priced at $141.17 on the NASDAQ, while SENS trades at $7.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PODD currently has a P/E ratio of 24.05, whereas SENS's P/E ratio is -3.51. In terms of profitability, PODD's ROE is +0.27%, compared to SENS's ROE of -1.66%. Regarding short-term risk, PODD is less volatile compared to SENS. This indicates lower risk in terms of short-term price fluctuations for PODD.Check SENS's competition here
Anika Therapeutics, Inc. (NASDAQ: ANIK)
PODD vs ANIK Comparison August 2026
Insulet Corp. (NASDAQ: PODD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PODD stands at 9.8B. In comparison, ANIK has a market cap of 286.7M. Regarding current trading prices, PODD is priced at $141.17 on the NASDAQ, while ANIK trades at $21.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PODD currently has a P/E ratio of 24.05, whereas ANIK's P/E ratio is 43.71. In terms of profitability, PODD's ROE is +0.27%, compared to ANIK's ROE of -0.03%. Regarding short-term risk, PODD is less volatile compared to ANIK. This indicates lower risk in terms of short-term price fluctuations for PODD.Check ANIK's competition here
Profound Medical Corp. (NASDAQ: PROF)
PODD vs PROF Comparison August 2026
Insulet Corp. (NASDAQ: PODD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PODD stands at 9.8B. In comparison, PROF has a market cap of 269.3M. Regarding current trading prices, PODD is priced at $141.17 on the NASDAQ, while PROF trades at $7.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PODD currently has a P/E ratio of 24.05, whereas PROF's P/E ratio is -5.98. In terms of profitability, PODD's ROE is +0.27%, compared to PROF's ROE of -0.56%. Regarding short-term risk, PODD is less volatile compared to PROF. This indicates lower risk in terms of short-term price fluctuations for PODD.Check PROF's competition here
RxSight, Inc. (NASDAQ: RXST)
PODD vs RXST Comparison August 2026
Insulet Corp. (NASDAQ: PODD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PODD stands at 9.8B. In comparison, RXST has a market cap of 259.1M. Regarding current trading prices, PODD is priced at $141.17 on the NASDAQ, while RXST trades at $6.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PODD currently has a P/E ratio of 24.05, whereas RXST's P/E ratio is -6.73. In terms of profitability, PODD's ROE is +0.27%, compared to RXST's ROE of -0.17%. Regarding short-term risk, PODD is less volatile compared to RXST. This indicates lower risk in terms of short-term price fluctuations for PODD.Check RXST's competition here
Monogram Orthopaedics, Inc. (NASDAQ: MGRM)
PODD vs MGRM Comparison August 2026
Insulet Corp. (NASDAQ: PODD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PODD stands at 9.8B. In comparison, MGRM has a market cap of 243.8M. Regarding current trading prices, PODD is priced at $141.17 on the NASDAQ, while MGRM trades at $6.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PODD currently has a P/E ratio of 24.05, whereas MGRM's P/E ratio is -12.00. In terms of profitability, PODD's ROE is +0.27%, compared to MGRM's ROE of -0.85%. Regarding short-term risk, PODD is more volatile compared to MGRM. This indicates higher risk in terms of short-term price fluctuations for PODD.Check MGRM's competition here
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL)
PODD vs FOCL Comparison August 2026
Insulet Corp. (NASDAQ: PODD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PODD stands at 9.8B. In comparison, FOCL has a market cap of 233.1M. Regarding current trading prices, PODD is priced at $141.17 on the NASDAQ, while FOCL trades at $6.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PODD currently has a P/E ratio of 24.05, whereas FOCL's P/E ratio is -8.00. In terms of profitability, PODD's ROE is +0.27%, compared to FOCL's ROE of -1.38%. Regarding short-term risk, PODD is less volatile compared to FOCL. This indicates lower risk in terms of short-term price fluctuations for PODD.Check FOCL's competition here
Nevro Corp. (NYSE: NVRO)
PODD vs NVRO Comparison August 2026
Insulet Corp. (NASDAQ: PODD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PODD stands at 9.8B. In comparison, NVRO has a market cap of 224.1M. Regarding current trading prices, PODD is priced at $141.17 on the NASDAQ, while NVRO trades at $5.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PODD currently has a P/E ratio of 24.05, whereas NVRO's P/E ratio is -1.91. In terms of profitability, PODD's ROE is +0.27%, compared to NVRO's ROE of -0.43%. Regarding short-term risk, PODD is more volatile compared to NVRO. This indicates higher risk in terms of short-term price fluctuations for PODD.Check NVRO's competition here
TriSalus Life Sciences, Inc. (NASDAQ: TLSI)
PODD vs TLSI Comparison August 2026
Insulet Corp. (NASDAQ: PODD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PODD stands at 9.8B. In comparison, TLSI has a market cap of 212.7M. Regarding current trading prices, PODD is priced at $141.17 on the NASDAQ, while TLSI trades at $5.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PODD currently has a P/E ratio of 24.05, whereas TLSI's P/E ratio is -3.34. In terms of profitability, PODD's ROE is +0.27%, compared to TLSI's ROE of +2.74%. Regarding short-term risk, PODD is less volatile compared to TLSI. This indicates lower risk in terms of short-term price fluctuations for PODD.Check TLSI's competition here
Avita Medical Inc. (NASDAQ: RCEL)
PODD vs RCEL Comparison August 2026
Insulet Corp. (NASDAQ: PODD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PODD stands at 9.8B. In comparison, RCEL has a market cap of 193M. Regarding current trading prices, PODD is priced at $141.17 on the NASDAQ, while RCEL trades at $7.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PODD currently has a P/E ratio of 24.05, whereas RCEL's P/E ratio is -4.95. In terms of profitability, PODD's ROE is +0.27%, compared to RCEL's ROE of +2.32%. Regarding short-term risk, PODD is less volatile compared to RCEL. This indicates lower risk in terms of short-term price fluctuations for PODD.Check RCEL's competition here
BioSig Technologies, Inc. (NASDAQ: BSGM)
PODD vs BSGM Comparison August 2026
Insulet Corp. (NASDAQ: PODD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PODD stands at 9.8B. In comparison, BSGM has a market cap of 191.1M. Regarding current trading prices, PODD is priced at $141.17 on the NASDAQ, while BSGM trades at $6.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PODD currently has a P/E ratio of 24.05, whereas BSGM's P/E ratio is -5.81. In terms of profitability, PODD's ROE is +0.27%, compared to BSGM's ROE of +15.26%. Regarding short-term risk, PODD is less volatile compared to BSGM. This indicates lower risk in terms of short-term price fluctuations for PODD.Check BSGM's competition here
Quanterix Corporation (NASDAQ: QTRX)
PODD vs QTRX Comparison August 2026
Insulet Corp. (NASDAQ: PODD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PODD stands at 9.8B. In comparison, QTRX has a market cap of 189.8M. Regarding current trading prices, PODD is priced at $141.17 on the NASDAQ, while QTRX trades at $4.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PODD currently has a P/E ratio of 24.05, whereas QTRX's P/E ratio is -2.52. In terms of profitability, PODD's ROE is +0.27%, compared to QTRX's ROE of -0.35%. Regarding short-term risk, PODD is more volatile compared to QTRX. This indicates higher risk in terms of short-term price fluctuations for PODD.Check QTRX's competition here
Xylo Technologies Ltd. (NASDAQ: MDGS)
PODD vs MDGS Comparison August 2026
Insulet Corp. (NASDAQ: PODD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PODD stands at 9.8B. In comparison, MDGS has a market cap of 178.9M. Regarding current trading prices, PODD is priced at $141.17 on the NASDAQ, while MDGS trades at $2.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PODD currently has a P/E ratio of 24.05, whereas MDGS's P/E ratio is -0.27. In terms of profitability, PODD's ROE is +0.27%, compared to MDGS's ROE of -0.51%. Regarding short-term risk, PODD is less volatile compared to MDGS. This indicates lower risk in terms of short-term price fluctuations for PODD.Check MDGS's competition here
Neuronetics, Inc. (NASDAQ: STIM)
PODD vs STIM Comparison August 2026
Insulet Corp. (NASDAQ: PODD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PODD stands at 9.8B. In comparison, STIM has a market cap of 165.6M. Regarding current trading prices, PODD is priced at $141.17 on the NASDAQ, while STIM trades at $2.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PODD currently has a P/E ratio of 24.05, whereas STIM's P/E ratio is -4.41. In terms of profitability, PODD's ROE is +0.27%, compared to STIM's ROE of -1.65%. Regarding short-term risk, PODD is less volatile compared to STIM. This indicates lower risk in terms of short-term price fluctuations for PODD.Check STIM's competition here
Inogen, Inc. (NASDAQ: INGN)
PODD vs INGN Comparison August 2026
Insulet Corp. (NASDAQ: PODD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PODD stands at 9.8B. In comparison, INGN has a market cap of 163.8M. Regarding current trading prices, PODD is priced at $141.17 on the NASDAQ, while INGN trades at $6.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PODD currently has a P/E ratio of 24.05, whereas INGN's P/E ratio is -6.65. In terms of profitability, PODD's ROE is +0.27%, compared to INGN's ROE of -0.13%. Regarding short-term risk, PODD is less volatile compared to INGN. This indicates lower risk in terms of short-term price fluctuations for PODD.Check INGN's competition here
Quipt Home Medical Corp. (NASDAQ: QIPT)
PODD vs QIPT Comparison August 2026
Insulet Corp. (NASDAQ: PODD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PODD stands at 9.8B. In comparison, QIPT has a market cap of 162.3M. Regarding current trading prices, PODD is priced at $141.17 on the NASDAQ, while QIPT trades at $3.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PODD currently has a P/E ratio of 24.05, whereas QIPT's P/E ratio is -15.87. In terms of profitability, PODD's ROE is +0.27%, compared to QIPT's ROE of -0.10%. Regarding short-term risk, PODD is more volatile compared to QIPT. This indicates higher risk in terms of short-term price fluctuations for PODD.Check QIPT's competition here
iCAD, Inc. (NASDAQ: ICAD)
PODD vs ICAD Comparison August 2026
Insulet Corp. (NASDAQ: PODD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PODD stands at 9.8B. In comparison, ICAD has a market cap of 106.3M. Regarding current trading prices, PODD is priced at $141.17 on the NASDAQ, while ICAD trades at $3.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PODD currently has a P/E ratio of 24.05, whereas ICAD's P/E ratio is -20.37. In terms of profitability, PODD's ROE is +0.27%, compared to ICAD's ROE of -0.18%. Regarding short-term risk, PODD is more volatile compared to ICAD. This indicates higher risk in terms of short-term price fluctuations for PODD.Check ICAD's competition here
Owlet, Inc. (NYSE: OWLT)
PODD vs OWLT Comparison August 2026
Insulet Corp. (NASDAQ: PODD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PODD stands at 9.8B. In comparison, OWLT has a market cap of 99.9M. Regarding current trading prices, PODD is priced at $141.17 on the NASDAQ, while OWLT trades at $5.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PODD currently has a P/E ratio of 24.05, whereas OWLT's P/E ratio is -39.43. In terms of profitability, PODD's ROE is +0.27%, compared to OWLT's ROE of +11.36%. Regarding short-term risk, PODD is less volatile compared to OWLT. This indicates lower risk in terms of short-term price fluctuations for PODD.Check OWLT's competition here
Lucid Diagnostics Inc. (NASDAQ: LUCD)
PODD vs LUCD Comparison August 2026
Insulet Corp. (NASDAQ: PODD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PODD stands at 9.8B. In comparison, LUCD has a market cap of 98.9M. Regarding current trading prices, PODD is priced at $141.17 on the NASDAQ, while LUCD trades at $0.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PODD currently has a P/E ratio of 24.05, whereas LUCD's P/E ratio is -2.61. In terms of profitability, PODD's ROE is +0.27%, compared to LUCD's ROE of -3.70%. Regarding short-term risk, PODD is less volatile compared to LUCD. This indicates lower risk in terms of short-term price fluctuations for PODD.Check LUCD's competition here
Solana Company (NASDAQ: HSDT)
PODD vs HSDT Comparison August 2026
Insulet Corp. (NASDAQ: PODD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PODD stands at 9.8B. In comparison, HSDT has a market cap of 98.7M. Regarding current trading prices, PODD is priced at $141.17 on the NASDAQ, while HSDT trades at $1.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PODD currently has a P/E ratio of 24.05, whereas HSDT's P/E ratio is -0.02. In terms of profitability, PODD's ROE is +0.27%, compared to HSDT's ROE of -1.55%. Regarding short-term risk, PODD is more volatile compared to HSDT. This indicates higher risk in terms of short-term price fluctuations for PODD.Check HSDT's competition here
Hancock Jaffe Laboratories (NASDAQ: HJLI)
PODD vs HJLI Comparison August 2026
Insulet Corp. (NASDAQ: PODD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PODD stands at 9.8B. In comparison, HJLI has a market cap of 98.3M. Regarding current trading prices, PODD is priced at $141.17 on the NASDAQ, while HJLI trades at $10.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PODD currently has a P/E ratio of 24.05, whereas HJLI's P/E ratio is N/A. In terms of profitability, PODD's ROE is +0.27%, compared to HJLI's ROE of -0.62%. Regarding short-term risk, PODD is less volatile compared to HJLI. This indicates lower risk in terms of short-term price fluctuations for PODD.Check HJLI's competition here